Brexpiprazole

Brexpiprazole, also known as OPC-34712, is a novel D2 dopamine partial agonist called serotonin-dopamine activity modulator (SDAM) approved for the treatment of schizophrenia, and as an adjunctive treatment for depression. Although it failed Phase II clinical trials for ADHD, it has been designed to provide improved efficacy and tolerability (e.g., less akathisia, restlessness and/or insomnia) over established adjunctive treatments for major depressive disorder (MDD). Brexpiprazole was approved on 7/10/2015 to treat schizophrenia and as an add on to an antidepressant to treat major depressive disorder
Supplier Ace Therapeutics
Product # SMD1304
CAS # 913611-97-9
Pricing Customizable size, Inquiry
Synonym OPC-34712; OPC 34712; OPC34712; Brexpiprazole; brand name Rexulti.
Product Category Lab-use Small Molecule Drugs
Chemical Formula C25H27N3O2S
Exact Mass 433.1824
Molecular Weight 433.57
Elemental Analysis C, 69.26; H, 6.28; N, 9.69; O, 7.38; S, 7.39
IUPAC/Chemical Name 7-(4-(4-(1-benzothiophen-4-yl)piperazin-1-yl)butoxy)quinolin-2(1H)-one
InChi Key ZKIAIYBUSXZPLP-UHFFFAOYSA-N
InChi Code InChI=1S/C25H27N3O2S/c29-25-9-7-19-6-8-20(18-22(19)26-25)30-16-2-1-11-27-12-14-28(15-13-27)23-4-3-5-24-21(23)10-17-31-24/h3-10,17-18H,1-2,11-16H2,(H,26,29)
SMILES Code O=C1NC2=C(C=CC(OCCCCN3CCN(C4=C5C=CSC5=CC=C4)CC3)=C2)C=C1
Appearance Solid powder
Purity >98% (or refer to the Certificate of Analysis)
Shipping Condition Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility Soluble in DMSO, not in water
Shelf Life >2 years if stored properly
Drug Formulation This drug may be formulated in DMSO
Stock Solution Storage 0 - 4℃ for short term (days to weeks), or -20℃ for long term (months).
HS Tariff Code 2934.99.9001
Class-2 Schizophrenia
Availability 2 Weeks
Feedback